CapsoVision appoints Dr. David Shields to board; Dr. Imperial resigns but remains consultant

CapsoVision, Inc

Dr. David Shields, a gastroenterologist with 40+ years experience and capsule endoscopy pioneer, appointed Class I director and Compensation Committee member effective July 1, 2026.
Dr. Joanne Imperial resigned as director effective July 1, 2026; no disagreement with management or board.
Dr. Imperial will continue as independent consultant at $600/hour, up to 5 hours/week, and received option for 10,000 shares vesting over 4 years.
Dr. Shields will provide clinical consulting at $600/hour, up to 3 hours/week, under a separate consulting agreement.
Dr. Imperial to advise on pancreatic cancer program and planned 2027 esophageal varices study using next-gen capsule platform.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. David S. Shields

Class I director

CV · CapsoVision, Inc

Effective: 2026-07-01
Filed: July 2, 2026, 4:10 PM ET

On July 1, 2026, the Board of Directors (the “Board”) of CapsoVision Inc. (the “Company”) appointed Dr. David Stanley Shields to serve as a Class I director of the Board and as a member of the Compensation Committee of the Board

Departed

Dr. Joanne Imperial

Class I director

CV · CapsoVision, Inc

Effective: 2026-07-01
Successor: Dr. David S. Shields
Filed: July 2, 2026, 4:10 PM ET

On July 1, 2026, Dr. Joanne Imperial stepped down from the Board as a Class I director and as a member of the Compensation Committee of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. David S. Shields was appointed as Class I director at CapsoVision, Inc.

Action: appointed
Role: Class I director

Exact text from the filing

On July 1, 2026, the Board of Directors (the “Board”) of CapsoVision Inc. (the “Company”) appointed Dr. David Stanley Shields to serve as a Class I director of the Board and as a member of the Compensation Committee of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Joanne Imperial departed as Class I director at CapsoVision, Inc.

Action: stepped down
Role: Class I director

Exact text from the filing

On July 1, 2026, Dr. Joanne Imperial stepped down from the Board as a Class I director and as a member of the Compensation Committee of the Board, effective immediately.

View on SEC.gov

CapsoVision, Inc filing history →

Source: SEC EDGAR

accession 0001378325-26-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.